Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Phase 2/3 Study of IV Amisulpride as Prevention of Post-operative Nausea and Vomiting in Pediatric Patients

NCT05546359 is registered in ClinicalTrials.gov with Acacia Pharma Ltd as lead sponsor.

NCT NCT05546359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05546359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Phase 2/3 Study of IV Amisulpride as Prevention of Post-operative Nausea and Vomiting in Pediatric Patients
Lead sponsor
Acacia Pharma Ltd
Phase
Phase 2/3
Overall status
Completed
Start date
January 18, 2024
Completion date
June 3, 2025
Enrollment
453 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

nausea and vomiting, postoperative